Patents by Inventor Daniel Sauder

Daniel Sauder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APOPTOTIC ENTITIES FOR USE IN TREATMENT OF NEURODEGENERATIVE AND OTHER NEUROLOGICAL DISORDERS
    Publication number: 20080131416
    Abstract: Treatment and/or prophylaxis, in mammalian patients, of neurodegenerative and other neurological medical disorders is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells, preferably those derived from the patient's own white blood cells, e.g. by extracorporeal treatment of the patient's blood cells to induce apoptosis and administration of the apoptotic bodies and/or cells so formed to the patient.
    Type: Application
    Filed: October 29, 2007
    Publication date: June 5, 2008
    Inventors: Anthony E. Bolton, Arkady Mandel, Daniel Sauder
  • APOPTOTIC ENTITIES FOR USE IN TREATMENT OF ENDOTHELIUM DYSFUNCTION DISORDERS
    Publication number: 20080063631
    Abstract: Treatment and/or prophylaxis of endothelial dysfunction-related disorders in mammalian patients is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells.
    Type: Application
    Filed: September 13, 2007
    Publication date: March 13, 2008
    Inventors: Anthony Bolton, Arkady Mandel, Daniel Sauder
  • APOPTOTIC ENTITIES FOR USE IN TREATMENT OF ENDOTHELIUM DYSFUNCTION DISORDERS
    Publication number: 20070298020
    Abstract: Treatment and/or prophylaxis of endothelial dysfunction-related disorders in mammalian patients is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells.
    Type: Application
    Filed: July 31, 2007
    Publication date: December 27, 2007
    Inventors: Anthony Bolton, Arkady Mandel, Daniel Sauder
  • Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
    Publication number: 20070087010
    Abstract: Treatment and/or prophylaxis, in mammalian patients, of neurodegenerative and other neurological medical disorders is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells, preferably those derived from the patient's own white blood cells, e.g. by extracorporeal treatment of the patient's blood cells to induce apoptosis and administration of the apoptotic bodies and/or cells so formed to the patient.
    Type: Application
    Filed: October 17, 2006
    Publication date: April 19, 2007
    Inventors: Anthony Bolton, Arkady Mandel, Daniel Sauder
  • Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
    Patent number: 7132285
    Abstract: Treatment and/or prophylaxis, in mammalian patients, of neurodegenerative and other neurological medical disorders is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells, preferably those derived from the patient's own white blood cells, e.g. by extracorporeal treatment of the patient's blood cells to induce apoptosis and administration of the apoptotic bodies and/or cells so formed to the patient.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: November 7, 2006
    Assignee: Vasogen Ireland Limited
    Inventors: Anthony E. Bolton, Arkady Mandel, Daniel Sauder
  • Treatment of Il-10 deficiencies
    Publication number: 20020150560
    Abstract: Mammalian disorders associated with a deficiency in the cytokine interleukin-10 (IL-10) can be alleviated by stimulating in vivo secretion and/or activity of IL-10 in the patient's blood or tissues by application of external stimulus.
    Type: Application
    Filed: May 10, 2002
    Publication date: October 17, 2002
    Inventors: Daniel Sauder, Arkady Mandel, Anthony Bolton
  • Apoptotic entities for use in treatment of endothelium dysfunction disorders
    Publication number: 20020058023
    Abstract: Treatment and/or prophylaxis of endothelial dysfunction-related disorders in mammalian patients is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells.
    Type: Application
    Filed: May 25, 2001
    Publication date: May 16, 2002
    Inventors: Anthony E. Bolton, Arkady Mandel, Daniel Sauder
  • Apoptotic entities for use in treatment of T-cell-mediated and inflammatory disorders
    Publication number: 20020051771
    Abstract: Treatment and/or prophylaxis of T-cell-mediated and inflammatory disorders in mammalian patients is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells, and administration of the apoptotic cells so formed to the patient.
    Type: Application
    Filed: May 25, 2001
    Publication date: May 2, 2002
    Inventors: Anthony E. Bolton, Arkady Mandel, Daniel Sauder
  • Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
    Publication number: 20020044924
    Abstract: Treatment and/or prophylaxis, in mammalian patients, of neurodegenerative and other neurological medical disorders is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells, preferably those derived from the patient's own white blood cells, e.g. by extracorporeal treatment of the patient's blood cells to induce apoptosis and administration of the apoptotic bodies and/or cells so formed to the patient.
    Type: Application
    Filed: May 25, 2001
    Publication date: April 18, 2002
    Inventors: Anthony E. Bolton, Arkady Mandel, Daniel Sauder